Genotype-guided dosingTaiwan algorithm for warfarin
AS-IRB01-100070
Phase 3 gene_therapy completed
Quick answer
Genotype-guided dosingTaiwan algorithm for warfarin for Stroke is a Phase 3 program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Stroke
- Phase
- Phase 3
- Modality
- gene_therapy
- Status
- completed